TM7SF3 expression based on
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Comparison Statistical significance Normal-vs-Primary 9.310600E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Cancer stage information is not available for 3 samples.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Stage1
8.305800E-01
Normal-vs-Stage2
9.710800E-01
Normal-vs-Stage3
2.889600E-01
Normal-vs-Stage4
6.006800E-01
Stage1-vs-Stage2
8.521000E-01
Stage1-vs-Stage3
2.797800E-01
Stage1-vs-Stage4
3.687600E-01
Stage2-vs-Stage3
3.253200E-01
Stage2-vs-Stage4
4.596000E-01
Stage3-vs-Stage4
1.439960E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Patient race information is not available for 5 samples.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Caucasian
9.317000E-01
Normal-vs-AfricanAmerican
8.727600E-01
Normal-vs-Asian
8.625800E-01
Caucasian-vs-AfricanAmerican
5.499400E-01
Caucasian-vs-Asian
8.831600E-01
AfricanAmerican-vs-Asian
6.858800E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Patient gender information is not available for 1 sample.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Male
9.545200E-01
Normal-vs-Female
9.054800E-01
Male-vs-Female
8.548600E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Patient age information is not available for 1 sample.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Age(21-40Yrs)
5.258800E-01
Normal-vs-Age(41-60Yrs)
7.951000E-01
Normal-vs-Age(61-80Yrs)
7.542200E-01
Normal-vs-Age(81-100Yrs)
6.122000E-01
Age(21-40Yrs)-vs-Age(41-60Yrs)
4.619800E-01
Age(21-40Yrs)-vs-Age(61-80Yrs)
6.694600E-01
Age(21-40Yrs)-vs-Age(81-100Yrs)
6.094000E-01
Age(41-60Yrs)-vs-Age(61-80Yrs)
6.993600E-02
Age(41-60Yrs)-vs-Age(81-100Yrs)
1.009820E-01
Age(61-80Yrs)-vs-Age(81-100Yrs)
8.979400E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Drinking status is not available for 80 samples.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Non Drinker
5.785000E-01
Normal-vs-Daily Drinker
3.862800E-01
Normal-vs-Weekly Drinker
6.905400E-01
Normal-vs-Occasional Drinker
5.401400E-01
Normal-vs-Social Drinker
7.952800E-01
Non Drinker-vs-Daily Drinker
3.591600E-01
Non Drinker-vs-Weekly Drinker
9.743200E-01
Non Drinker-vs-Occasional Drinker
6.053500E-02
Non Drinker-vs-Social Drinker
1.286370E-01
Daily Drinker-vs-Weekly Drinker
5.382600E-01
Daily Drinker-vs-Occasional Drinker
3.028000E-02
Daily Drinker-vs-Social Drinker
5.519500E-02
Weekly Drinker-vs-Occasional Drinker
7.852300E-02
Weekly Drinker-vs-Social Drinker
2.791400E-01
Occasional Drinker-vs-Social Drinker
2.954600E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma
Subtype descriptions Grade 1 Well differentiated (low grade)
Grade 2 Moderately differentiated (intermediate grade) Grade 3 Poorly differentiated (high grade)
Grade 4 Undifferentiated (high grade)
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Grade 1
4.467800E-02
Normal-vs-Grade 2
5.849500E-02
Normal-vs-Grade 3
5.515700E-02
Normal-vs-Grade 4
1.000000E+00
Grade 1-vs-Grade 2
9.832800E-01
Grade 1-vs-Grade 3
3.565800E-02
Grade 1-vs-Grade 4
4.467800E-02
Grade 2-vs-Grade 3
1.531890E-02
Grade 2-vs-Grade 4
5.849500E-02
Grade 3-vs-Grade 4
5.515700E-02
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Diabetes status information is not available for 30 samples.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Diabetic
4.893800E-01
Normal-vs-NonDiabetic
9.532400E-01
Diabetic-vs-NonDiabetic
8.672100E-02
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Pancreatitis status is not available for 39 samples.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Pancreatitis
9.897800E-01
Normal-vs-NoPancreatitis
8.507600E-01
Pancreatitis-vs-NoPancreatitis
6.984800E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Nodal metastais status is not available for 1 sample and cancer in nearby lymph nodes cannot be measured (NX) in 4 samples.
pathologic_N descriptions N0 No regional lymph node metastasis
N1 Metastases in 1 to 3 axillary lymph nodes N2 Metastases in 4 to 9 axillary lymph nodes
N3 Metastases in 10 or more axillary lymph nodes
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-N0
7.539200E-01
Normal-vs-N1
9.808000E-01
N0-vs-N1
3.633200E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Whole exome sequencing data is not available for 3 samples.
TP53 mutation status is obtained from TCGA whole exome sequencing data. We downloaded Mutation Annotation Format (MAF) files (derived from VarScan2) from Genomic Data Commons portal. The sample with/without TP53 mutation were matched with RNA-seq data
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-TP53-Mutant
7.470000E-01
Normal-vs-TP53-NonMutant
7.522600E-01
TP53-Mutant-vs-TP53-NonMutant
9.397400E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
